Filana Therapeutics, Inc.

US$0.45As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:FLNAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (19.41%)
Div yield —
ROE (60.48%)
Biotechnology
Beta (5Y) (0.45)
PE TTM —
TSR TTM (86.11%)
Mkt cap US$21.87M
ROIC (11.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.525
16.06%
(45.49%)
Hold 0|7|5|9|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
2.64%
15.71%
10.36%
20.88%
Revenue$M
1.028
1.046
1.095
1.068
(4.86%)
(1.68%)
4.48%
2.93%
Peers (US$21.87M)
Cap (US$)
PE
21.48M
—
21.97M
17.86x
Capital
TTM
5Y
10Y
Leveragex
0.973
3.760
2.615
EBIT/Intx
1.382
1.141
1.467
Own earn%
53.54
(16.76)
17.65
Sh yield%
14.03
55.58
53.22
Owners
Insiders/Inst%
10.12
42.50
Short interest%
5.59
SBC / revenue%
4.08
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
29–36
$1 testx
—
Incr. ROIC%
6